Skip to main content
SpringerLink
Log in

Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Depletion of reduced glutathione occurs in the substantia nigra in Parkinson's disease and in incidental Lewy body disease (presymptomatic Parkinson's disease) which may implicate oxidative stress in the neurode-generative process. In this study mercury orange fluorescent staining and immunostaining with an antibody to reduced glutathione have been used to determine the distribution of reduced glutathione in the substantia nigra in Parkinson's disease compared with normal individuals.

Mercury orange staining showed moderate background levels of fluorescence in the neuropil in both control and Parkinson's disease substantia nigra and localised reduced glutathione to the somata of melanized nigral neurons and glial elements of the neuropil. Neuronal nuclei revealed a relative lack of fluorescence after mercury orange staining. There was a significant depletion of reduced glutathione in surviving neurons in Parkinson's disease compared to nerve cell populations in control tissue. Mercury orange fluorescence indicated a high concentration of reduced glutathione in a subpopulation of non-neuronal cells, most likely astrocytes or microglia.

Immunohistochemical examination of nigral tissue from the same Parkinson's disease and control patients with an antibody to glutathione showed staining in neuronal perikarya and axonodendritic processes of melanized nigral neurons which was generally most intense in control neurons. Moderately intense staining of the background neuropil, most prominent in control nigras, and staining of capillary walls was also detected. Intense staining was seen in cells with the morphological features of glial cells in both control and PD nigra.

These data show a significant presence of reduced glutathione in the cell bodies and axons of nigral neurons. They are in agreement with biochemical studies showing depletion of reduced glutathione in substantia nigra in Parkinson's disease, and indicate a significant loss of neuronal reduced glutathione in surviving nigral neurons in Parkinson's disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

GFAP :

glial fibrillary acidic protein

GSH :

reduced glutathione

GSSG :

oxidized glutathione

ILBD :

incidental Lewy body disease

PBS :

phosphate-buffered saline

PD :

Parkinson's disease

References

  • Amara A, Coussemacq M, Geffard M (1994) Antibodies to reduced glutathione. Brain Res 659: 237–242

    Google Scholar 

  • Asghar K, Reddy BG, Krishna G (1975) Histochemical localisation of glutathione in tissues. J Histochem Cytochem 23: 774–779

    Google Scholar 

  • Benzi G, Pastoris O, Marzatico F, Villa RF (1992) The mitochondrial electron transfer alteration as a factor involved in the aging brain. Neurobiol Aging 12: 361–368

    Google Scholar 

  • Bridges RJ, Koh J-Y, Hatalski CG, Cotman CW (1991) Increased excitotoxic vulnerability of cortical cultures with reduced levels of glutathione. Eur J Pharmacol 192: 199–200

    Google Scholar 

  • Chau RMW, Skaper SD, Varon S (1988) Peroxidative block of glucose utilization and survival in CNS neuronal cultures. Neurochem Res 13: 611–616

    Google Scholar 

  • Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F (1993) Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52: 1–6

    Google Scholar 

  • Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Jenner P, Marsden C (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurogedenerative disease affecting the basla ganglia. Brain 114: 1953–1975

    Google Scholar 

  • Dexter DT, Sian J, Rose S, Hindmarsh JG, Mann VM, Cooper JM, Wells FR, Danial SE, Lees AJ, Schapira AHV, Jenner P, Marsden CD (1994) Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease. Ann Neurol 35: 38–44

    Google Scholar 

  • Di Monte DA, Chan P, Sandy MS (1992) Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage? Ann Neurol 32: S111-S115

    Google Scholar 

  • Fearnley JM, Lees AJ (1991) Aging and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283–2301

    Google Scholar 

  • Forno LS (1969) Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases). Relationship to parkinsonism. J Am Geriatr Soc 17: 557–575

    Google Scholar 

  • Gibb WRG (1986) Idiopathic Parkinson's disease and the Lewy body disorders. Neuropathol Appl Neurobiol 12: 223–234

    Google Scholar 

  • Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51: 745–752

    Google Scholar 

  • Han S-K, Mytilineou C, Cohen G (1996) L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. J Neurochem 66: 501–510

    Google Scholar 

  • Heafield TH, Fearn S, Steventon GB, Waring RH, Williams AC, Sturman SG (1990) Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett 110: 216–220

    Google Scholar 

  • Hjelle OP, Chaudhry FA, Ottersen OP (1994) Antisera to glutathione: characterization and immunocytochemical application to the rat cerebellum. Eur J Neurosci 6: 793–804

    Google Scholar 

  • Huang J, Philbert MA (1995) Distribution of glutathione and glutathione-related enzyme systems in mitochondria and cytosol of cultured cerebellar astrocytes and granule cells. Brain Res 680: 16–22

    Google Scholar 

  • Jain A, Martensson J, Stole E, Auld PAM, Meister A (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci USA 88: 1913–1917

    Google Scholar 

  • Jenner P, Dexter DT, Sian J, Schapira AHV, Marsden CD (1992) Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann Neurol 32: 582–587

    Google Scholar 

  • Jenner P, Schapira AHV, Marsden CD (1992) New insights into the cause of Parkinson's disease. Neurology 42: 2241–2250

    Google Scholar 

  • Kirstein CL, Coopersmith R, Bridges RJ, Leon M (1991) Glutathione levels in olfactory and non-olfactory neural structures of rats. Brain Res 543: 341–346

    Google Scholar 

  • Makar TK, Nefergaard M, Preuss A, Gelbard AS, Perumal AS, Cooper AJL (1994) Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J Neurochem 62: 45–53

    Google Scholar 

  • Marttila RJ, Lorentz H, Rinne UK (1988) Oxygen toxicity protecting enzymes in Parkinson's disease: increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 86: 321–331

    Google Scholar 

  • McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988) Rate of cell death in parkinsonism indicates an active neuropathological process. Ann Neurol 24: 574–576

    Google Scholar 

  • McGeer PL, Kawamata T, Douglas GW, et al (1993) Microglia in degenerative neurological disease. Glia 7: 84–92

    Google Scholar 

  • Meister A (1992) On the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol 44: 1905–1915

    Google Scholar 

  • Meister A (1995) Mitochondrial changes associated with gluthatione deficiency. Biochim Biophys Acta 1271: 35–42

    Google Scholar 

  • Perry TL, Yong VW (1986) Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67: 269–274

    Google Scholar 

  • Perry TL, Godwin DV, Hansen S (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency. Neurosci Lett 33: 305–310

    Google Scholar 

  • Philbert MA, Beiswanger CD, Waters DK, Reuhl KR, Lowndes HE (1991) Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localisation by mercury orange and O-phthaldialdiadehyde-induced histofluorescence. Toxicol Appl Pharmacol 107: 215–227

    Google Scholar 

  • Pileblad E, Fornstedt B, Magnusson T (1989) Reduction of brain glutathione by L-buthione sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum. J Neurochem 52: 978–980

    Google Scholar 

  • Pileblad E, Erikksson PS, Hansson E (1991) The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem. J Neural Transm 86: 43–49

    Google Scholar 

  • Raps SP, Lai JCK, Hertz L, Cooper AJL (1989) Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 493: 398–401

    Google Scholar 

  • Riederer P, Sofic E, Rausch W-D, Schmidt B, Reynolds GB, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains. J Neurochem 52: 515–520

    Google Scholar 

  • Sagara J, Miura K, Bannai S (1993) Maintenance of neuronal glutathione by glial cells. J Neurochem 61: 1672–1676

    Google Scholar 

  • Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989) A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53: 692–697

    Google Scholar 

  • Schapira AHV, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) The anatomic and disease specificity of NADH CoQ reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55: 2142–2145

    Google Scholar 

  • Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia. Ann Neurol 36: 348–355

    Google Scholar 

  • Sian J, Dexter DT, Lees AJ, Jenner P, Marsden CD (1994) Glutathione-related enzymes in brain in Parkinson's disease. Ann Neurol 36: 356–361

    Google Scholar 

  • Slivka A, Mytilineou C, Cohen G (1987) Histochemical evaluation of gluthathione in brain. Brain Res 409: 275–284

    Google Scholar 

  • Wefers H, Sies H (1988) The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. Eur J Biochem 174: 353–357

    Google Scholar 

  • Zängerle L, Cuénod M, Winterhalter KH, Do KQ (1992) Screening of thiol compounds: depolarization-induced release of glutathione and cysteine from rat brain slices. J Neurochem 59: 181–189

    Google Scholar 

Download references

Author information

Author notes

  1. P. Jenner

    Present address: Neurodegenerative Diseases Research Centre, Biomedical Sciences Division, King's College, UK

Authors and Affiliations

  1. Neurodegenerative Diseases Research Centre, Biomedical Sciences Division, King's College, UK

    R. K. B. Pearce & A. Owen

  2. Parkinson's Disease Society Brain Bank, University Department of Clinical Neurology, Institute of Neurology, National Hospital, London, UK

    R. K. B. Pearce, S. Daniel & C. D. Marsden

Authors
  1. R. K. B. Pearce
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Owen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Daniel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Jenner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. D. Marsden
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pearce, R.K.B., Owen, A., Daniel, S. et al. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J. Neural Transmission 104, 661–677 (1997). https://doi.org/10.1007/BF01291884

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01291884

Keywords

Search

Navigation